Purpose of reviewFatty liver disease is increasingly common worldwide and is associated with an increased risk of cardiovascular disease (CVD).Recent findingsThis review describes the cardiovascular outcomes, clinical assessment and management as well as the impact of emerging drug treatment on CVD risk.SummaryPatients with fatty liver require CVD risk assessment including consideration of statin therapy. Emerging therapeutic drugs for fatty liver may have both adverse and beneficial effects on CVD risk.
|Number of pages
|Current Opinion in Endocrinology, Diabetes and Obesity
|Published - 1 Apr 2023